MedPath

Observation study of continuous glucose monitoring for postoperative patients in esophageal cancer

Not Applicable
Conditions
Esophageal cancer
Registration Number
JPRN-UMIN000044115
Lead Sponsor
Kitasato University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who had not radical surgery. 2) Salvage surgery case. 3) During the other anti-cancer treatment (chemotherapy, radiation therapy, etc.). 4) Diabetes is being treated with oral hypoglycemic agents and insulin (perioperative insulin administration is acceptable). 5) Enteral nutritional supplements and other dietary supplements are also used. 6) There are some pathological conditions that the investigator deems inappropriate.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
14-day continuous glucose monitoring
Secondary Outcome Measures
NameTimeMethod
5-day dietary and symptom recording
© Copyright 2025. All Rights Reserved by MedPath